Orth Andrew C. (CIK 0001860010)

Latest company ownership

Role: Chief Commercial Officer
Shares held
12,500
Last filed at
Jun 9, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jun 9, 2023 Jun 9, 2023 Krystal Biotech, Inc. Chief Commercial Officer Sell 5.0 -12,500 -99.21% $1.6M